Literature DB >> 18078447

Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress.

Daniele De Filippis1, Teresa Iuvone, Giuseppe Esposito, Luca Steardo, G Herman Arnold, A Pelckmans Paul, G De Man Joris, Y De Winter Benedicte.   

Abstract

A growing number of reports demonstrate that a pro-inflammatory and oxidative condition is related to the pathogenesis and the progression of endotoxin-induced septic shock and that antioxidants may have therapeutic potential in lipopolysaccharide (LPS)-induced sepsis. Melatonin has been shown to possess potent antioxidant properties in several models of inflammation in mice and rats. In the present study we focused on the possible protective mechanism of melatonin in preventing gastrointestinal (GI) disturbances induced by LPS in mice. In fact, mice treated with LPS showed a reduced gastric emptying of solid beads. Also the geometric center, representing the relative distribution of the solid beads throughout the entire GI tract, was significantly reduced in LPS-treated mice confirming that sepsis leads to a disturbed GI motility in mice. Melatonin completely reversed the LPS-induced motility disturbance. This beneficial effect of melatonin is associated with a reduction in lipid peroxidation, MAPK activation, NF-kappaB activation, iNOS transcription and expression and nitrite production in intestinal tissue from septic mice. These results demonstrate that melatonin prevents the LPS-induced GI disturbances in mice switching off the pro-oxidant pathways induced by the endotoxin. Therefore, it is reasonable to propose melatonin as a molecule with therapeutic potential for the treatment of systemic inflammation by interfering at the earliest steps of activation of the oxidative and pro-inflammatory cascade.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18078447     DOI: 10.1111/j.1600-079X.2007.00526.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  13 in total

Review 1.  Utilizing melatonin to combat bacterial infections and septic injury.

Authors:  Wei Hu; Chao Deng; Zhiqiang Ma; Dongjin Wang; Chongxi Fan; Tian Li; Shouyin Di; Bing Gong; Russel J Reiter; Yang Yang
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

2.  Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.

Authors:  M Bashashati; M A Storr; S P Nikas; J T Wood; G Godlewski; J Liu; W Ho; C M Keenan; H Zhang; S O Alapafuja; B F Cravatt; B Lutz; K Mackie; G Kunos; K D Patel; A Makriyannis; J S Davison; K A Sharkey
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  Sleep, immunity and inflammation in gastrointestinal disorders.

Authors:  Tauseef Ali; James Choe; Ahmed Awab; Theodore L Wagener; William C Orr
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 4.  Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility.

Authors:  Benedicte-Y De Winter; Joris-G De Man
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

Review 5.  Distribution, function and physiological role of melatonin in the lower gut.

Authors:  Chun-Qiu Chen; Jakub Fichna; Mohammad Bashashati; Yong-Yu Li; Martin Storr
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

6.  Short- and Long-Term Protective Effects of Melatonin in a Mouse Model of Sepsis-Associated Encephalopathy.

Authors:  Mu-Huo Ji; De-Guo Xia; Lan-Yue Zhu; Xia Zhu; Xiao-Yan Zhou; Jiang-Yan Xia; Jian-Jun Yang
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

7.  Melatonin reduces ulcerative colitis-associated local and systemic damage in mice: investigation on possible mechanisms.

Authors:  P P Trivedi; G B Jena
Journal:  Dig Dis Sci       Date:  2013-08-23       Impact factor: 3.199

8.  Value of caffeic acid phenethyl ester pretreatment in experimental sepsis model in rats.

Authors:  Ozlem Alici; Havva Sahin Kavakli; Cemile Koca; Neriman Defne Altintas; Murat Aydin; Suleyman Alici
Journal:  Mediators Inflamm       Date:  2015-04-08       Impact factor: 4.711

Review 9.  Melatonin: buffering the immune system.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Nuria Alvarez-Sánchez; Ana Rodríguez-Rodríguez; Juan M Guerrero
Journal:  Int J Mol Sci       Date:  2013-04-22       Impact factor: 5.923

10.  Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?

Authors:  Maria-Cristina Porfirio; Juliana Paula Gomes de Almeida; Maddalena Stornelli; Silvia Giovinazzo; Diane Purper-Ouakil; Gabriele Masi
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.